Update on Federal Controlled Substance Dispensing Responsibilities
David Brushwood, RPH, JD
Professor of Pharmaceutical Outcomes and Policy
University of Florida College of Pharmacy
FACULTY DISCLOSURE STATEMENTS:
David Brushwood, RPH, JD, has no real or apparent conflicts of interest in relation to this program.
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-11-031-H03-P; 0430-0000-11-031-H03-T
Credits: 2.0 hours (0.20 ceu)
Type of Activity: Knowledge
This accredited activity is targeted to pharmacists and pharmacy technicians.
Exam processing and other inquiries and booklet orders to:
CE Customer Service: (800) 825-4696 or email@example.com
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.
The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.
The purpose of this lesson is to summarize recent changes to federal controlled substance laws.
After completing this activity, the participant should be able to:
- List the requirements for pharmacy practice that have recently been implemented by the Drug Enforcement Administration;
- Describe the implications for pharmacy practice of the mandate to limit access to controlled substances, while also allowing their legitimate medicinal use;
- Discuss pharmacy practice patterns that are influenced by the federal regulation of controlled substances; and
- Describe the public health justification for restricting pharmacy practice so as to reduce the illicit availability of controlled substances.